| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0008 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.09 | 0.003 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.005 |